Ensuring pain relief for children at the end of life

Pain Research and Management

Volumn 11, Issue 3, 2006, Pages 163-172

  Grégoire, Marie Claude ^a,b   Frager, Gerri ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

Children; End of life; Opioids; Pain, palliative care; Pediatric

Indexed keywords

ANTINEOPLASTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CODEINE; DIPHENHYDRAMINE; FENTANYL; HYDROMORPHONE; HYDROXYZINE; LEVOMEPROMAZINE; LORAZEPAM; MORPHINE; NALOXONE; ONDANSETRON; PARACETAMOL; RANITIDINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ANALGESIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CASE REPORT; CHILD BEHAVIOR; CHILD HEALTH CARE; CLINICAL FEATURE; CLINICAL OBSERVATION; CYANOSIS; DISEASE COURSE; DRUG INFUSION; DRUG SUBSTITUTION; FEMALE; GENERAL CONDITION DETERIORATION; HEART FAILURE; HUMAN; HYPOXEMIA; LOW DRUG DOSE; MUCOSA INFLAMMATION; PAIN ASSESSMENT; PRESCHOOL CHILD; PRURITUS; RESPIRATORY TRACT DISEASE; SEDATION; STOMACH TUBE; TERMINAL CARE; TREATMENT FAILURE; TREATMENT PLANNING; TYPHLITIS;

EID: 33748654399     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/608536     Document Type: Article

References (70)

1. Drake R, Frost J, Collins JJ. The symptoms of dying children. J Pain Symptom Manage 2003;26:594-603.
2. Martin JA, Kochanek KD, Strobino DM, Guyer B, MacDorman MF. Annual summary of vital statistics - 2003. Pediatrics 2005;115:619-34.
3. Wolfe J, Grier HE, Klar N, et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med 2000;342:326-33.
4. Hongo T, Watanabe C, Okada S, et al. Analysis of the circumstances at the end of life in children with cancer: Symptoms, suffering and acceptance. Pediatr Int 2003;45:60-4.
5. Goldman A, Hewitt M, Collins GS, Childs M, Hain R; United Kingdom Children's Cancer Study Group/Paediatric Oncology Nurses' Forum Palliative Care Working Group. Symptoms in children/young people with progressive malignant disease: United Kingdom Children's Cancer Study Group/Paediatric Oncology Nurses Forum Survey. Pediatrics 2006;117:e1179-86.
6. Jalmsell L, Kreicberg U, Onelov E, Steineck G, Henter JI. Symptoms affecting children with malignancies during the last month of life: A nationwide follow-up. Pediatrics 2006;117:1314-20.
7. Finley GA, McGrath PJ, eds. Measurement of Pain in Infants and Children. Seattle: IASP Press, 1998.
8. Franck LS, Greenberg CS, Stevens B. Pain assessment in infants and children. Pediatr Clin North Am 2000;47:487-512.
9. Von Baeyer C. Children's self-reports of pain intensity: Scale selection, limitations, and interpretation. Pain Res Manag 2006;11:157-62.
10. Collins JJ, Byrnes ME, Dunkel IJ, et al. The measurement of symptoms in children with cancer. J Pain Symptom Manage 2000;19:363-77.
11. Collins JJ, Devine TD, Dick GS, et al. The measurement of symptoms in young children with cancer: The validation of the Memorial Symptom Assessment Scale in children aged 7-12. J Pain Symptom Manage 2002;23:10-6.
12. Gauvain-Piquard A, Rodary C, Rezvani A, Serbouti S. The development of the DEGR(R): A scale to assess pain in young children with cancer. Eur J Pain 1999;3:165-76.
13. Widger KA, Wilkins K. What are the key components of quality perinatal and pediatric end-of-life care? A literature review. J Palliat Care 2004;20:105-12.
14. Contro N, Larson J, Scofield S, Sourkes B, Cohen H. Family perspectives on the quality of pediatric palliative care. Arch Pediatr Adolesc Med 2002;156:14-9.
15. Mack JW, Hilden JM, Watterson J, et al. Parent and physician perspectives on quality of care at the end of life in children with cancer. J Clin Oncol 2005;23:9155-61.
16. Freeman K, O'Dell C, Meola C. Childhood brain tumors: Children's and siblings concerns regarding the diagnosis and phase of illness. J Pediatr Oncol Nurs 2003;20:133-40.
17. Galloway KS, Yaster M. Pain and symptom control in terminally ill children. Pediatr Clin North Am 2000;47:711-46.
18. Goldman A, Frager G, Pomietto M. Pain and palliative care. In: Schechter NL, Berde CB, Yaster M, eds. Pain in Infants, Children, and Adolescents, 2nd edn. Philadelphia: Lippincott Williams & Wilkins, 2003:539-62.
19. Kutmer L. Pain - an integrative approach. In: Goldman A, Hain R, Liben S, eds. Oxford Textbook of Palliative Care for Children. Oxford: Oxford University Press, 2006:332-341.
20. Scrace J. Complementary therapies in palliative care of children with cancer: A literature review. Paediatr Nurs 2003;15:36-9.
21. WHO Ladder: Cancer Pain Relief and Palliative Care. Technical Report Series 804. Geneva: World Health Organization, 1990.
22. World Health Organization. Cancer Pain Relief and Palliative Care in Children. Geneva, Switzerland: World Health Organization, 1998.
23. Malcom M, Scarpi E, Modonesi C, et al. A validation study of the WHO analgesic ladder: A two-step vs three-step strategy. Support Care Cancer 2005;13:888-894.
24. Miser AW, Miser JS, Clark BS. Continuous intravenous infusion of morphine sulfate for control of severe pain in children with terminal malignancy. J Pediatr 1980;96:930-2.
25. Miser AW, Davis DM, Hughes CS, Mulne AF, Miser JS. Continuous subcutaneous infusion of morphine in children with cancer. Am J Dis Child 1983;137:383-5.
26. Hain RD, Miser A, Devins M, Wallace WH. Strong opioids in pediatric palliative medicine. Paediatr Drugs 2005;7:1-9.
27. Yaster M, Kost-Byerly S, Maxwell LG. Opioid agonists and antagonists. In: Schechter NL, Berde CB, Yaster M, eds. Pain in Infants, Children, and Adolescents, 2nd edn. Philadelphia: Lippincott Williams & Wilkins, 2003:181-224.
28. Noyes M, Irving H. The use of transdermal fentanyl in pediatric oncology palliative care. Am J Hosp Palliat Care 2001;18:411-6.
29. Hunt A, Goldman A, Devine T, et al. Transdermal fentanyl for pain relief in a paediatric palliative care population. Palliat Med 2001;15:405-412.
30. Finkel JC, Finley GA, Greco C, Weisman SJ, Zeltzer L. Transdermal fentanyl in the management of children with chronic severe pain. Cancer 2005;104:2847-57.
31. Kokki H, Rasanen I, Lasalmi M, et al. Comparison of oxycodone pharmacokinetics after buccal and sublingual administration in children. Clin Pharmacokinet 2006;45:745-54.
32. Engelhardt T, Crawford M. Sublingual morphine may be a suitable alternative for pain control in children in the postoperative period. Paediatr Anaesth 2001;11:81-3.
33. Mystakidou K, Katsouda E, Parpa E, Vlahos L, Tsiatas ML. Oral transmucosal fentanyl citrate: Overview of pharmacological and clinical characteristics. Drug Deliv 2006;13:269-76.
34. Aronoff GM, Brennan MJ, Pritchard DD, Ginsberg B. Evidence-based oral transmucosal fentanyl citrate (OTFC) dosing guidelines. Pain Med 2005;6:305-14.
35. Roberts R, Brack A, Blakeney P. A double-blind study of the analgesic efficacy of oral transmucosal fentanyl citrate and oral morphine in pediatric patients undergoing burn dressing change and tubbing. J Burn Care Rehabil 2003;24:351-5.
36. Collins JJ, Grier HE, Sethna NF, et al. Regional anesthesia for pain associated with terminal pediatric malignancy. Pain 1996;65:63-9.
37. Cherney NJ, Foley KM. Nonopioid and opioid analgesic pharmacotherapy of cancer pain. Hematol Oncol Clin North Am 1996;10:79-102.
38. Frager G. Pediatric Palliative care. In: Joishy SK, ed. Palliative Medicine Secrets. Philadelphia: Hanley & Belfus, Inc, 1999:157-73.
39. Monitto CL, Greenberg RS, Kost-Byerly S, et al. The safety and efficacy of parent-/nurse-controlled analgesia in patients less than six years of age. Anesth Analg 2000;91:573-9.
40. Berde CB, Solodiuk J. Multidisciplinary programs for management of acute and chronic pain in children. In: Schechter NL, Berde CB, Yaster M, eds. Pain in Infants, Children, and Adolescents, 2nd edn. Philadelphia: Lippincott Williams & Wilkins, 2003:471-86.
41. Drake R, Hain R. Pain - Pharmacological management. In: Goldman A, Hain R, Liben S, eds. Oxford Textbook of Palliative Care for Children. Oxford: Oxford University Press, 2006:304-31.
42. Meissner W, Schmidt U, Hartmann M, et al. Oral naloxone reverses opioid-associated constipation. Pain 2000:84:105-9.
43. Kurz A, Sessler DI. Opioid-induced bowel dysfunction. Drugs 2003;63:649-71.
44. Kuraishi Y, Yamaguchi T, Miyamoto T. Itch-scratch responses induced by opioids through central mu opioid receptors in mice. J Biomed Sci 2000;7:248-52.
45. Ko MC, Song MS, Edwards T, et al. The role of central mu opioid receptors in opioid-induced itch in primates. J Pharmacol Exp Ther 2004;310:169-76.
46. Drake R, Longworth J, Collins JJ. Opioid rotation in children with cancer. J Palliat Med 2004;7:419-21.
47. Glare P, Pereira G, Kristjanson LJ, Stockler M, Tattersall M. Systematic review of the efficacy of antiemetics in the treatment if nausea in patients with far-advanced cancer. Support Care Cancer 2004;12:432-40.
48. Vickers AJ, Cassileth BR. Unconventional therapies for cancer and cancer-related symptoms. Lancet Oncol 2001;2:226-32.
49. Jones PD, Wilkinson IA. Massive opioid requirements in children with disseminated central nervous system disease. J Pediatr 1996;128:864-5.
50. Burns JF, Mitchell C, Ourwater KM, et al. End-of-life care in the pediatric intensive unit after the forgoing of life-sustaining treatment. Crit Care Med 2000;28:3060-6.
51. Truog RD, Cist AF, Brackett SE, et al. Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Study of Critical Care Medicine. Crit Care Med 2001;29:2332-48.
52. Partridge JC, Wall SN. Analgesia for dying infants whose life support is withdrawn or withheld. Pediatrics 1997;99:76-9.
53. Sirkia K, Hovi L, Pouttu J, Saarinen-Pihkala UM. Pain medication during terminal care of children with cancer. J Pain Symptom Manage 1998;15:220-6.
54. Siden H, Nalewajek. High dose opioids in pediatric palliative care. J Pain Symptom Manage 2003;25:397-9.
55. Collins JJ, Grier HE, Kinney HC, Berde CB. Control of severe pain in children with terminal malignancy. J Pediatr 1995;126:653-7.
56. Collins JJ, Berde CB, Grier HE, et al. Massive opioid resistance in an infant with localized metastasis to the midbrain periaqueductal gray. Pain 1995;63:271-5.
57. Robinson WM, Ravilly S, Berde C, Wohl ME. End-of-life care in cystic fibrosis. Pediatrics 1997;100:205-9.
58. McGrath PA. Pain control. In: Doyle D, Hanks GWC, MacDonald N, eds. Oxford Texbook of Palliative Medicine, 2nd edn. New York: Oxford University Press, 1998:1013-31.
59. Liben S. Pediatric palliative medicine: Obstacles to overcome. J Palliat Care 1996;12:24-8.
60. Liben S, Goldman A. Home care for children with life-threatening illness. J Palliat Care 1998;14:33-38.
61. McGrath PJ, Finley GA. Attitudes and beliefs about medication and pain management in children. J Palliat Care 1996;12:46-50.
62. Chaffee S. Pediatric palliative care. Prim Care 2001;28:365-90.
63. Berman JS, Symonds C, Birch R. Efficacy of two cannabis based medicinal extracts for relief if central neuropathic pain from brachial plexus avulsion: Results of a randomized controlled trial. Pain 2004;112:299-306.
64. Notcutt W, Price M, Miller R, et al. Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 'N of 1' studies. Anaesthesia 2004;59:440-52.
65. Luger NM, Mach DB, Sevcik MA, Mantyh PW. Bone cancer pain: From model to mechanism to therapy. J Pain Symptom Manage 2005;29(Suppl 5):S32-S46.
66. Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP. Molecular mechanisms of cancer pain. Nat Rev Cancer 2002;2:201-9.
67. Viscusi ER, Reynolds L, Chung F, Atkinson LE, Khanna S. Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: A randomized controlled trial. JAMA 2004;291:1333-41.
68. Groopman J. The Pediatric Gap. The New Yorker, January 10, 2005.
69. Roberts R, Rodriguez W, Murphy D, Crescenzi T. Pediatric drug labeling: Improving the safety and efficacy of pediatric therapies. JAMA 2003;290:905-11
70. Graham R, Dussel V, Wolfe J. Research. In: Goldman A, Hain R, Liben S, eds. Oxford Textbook of Palliative Care for Children. Oxford: Oxford University Press, 2006:613-47.